BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27441838)

  • 21. Metabolomics analysis of saliva from patients with primary Sjögren's syndrome.
    Kageyama G; Saegusa J; Irino Y; Tanaka S; Tsuda K; Takahashi S; Sendo S; Morinobu A
    Clin Exp Immunol; 2015 Nov; 182(2):149-53. PubMed ID: 26201380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the mechanism of Jieduquyuziyin prescription on systemic lupus erythematosus by GC-MS-based urine metabolomics.
    Wei J; Gao J; Ding X
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28869288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
    Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
    Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diaphragmatic muscle thickness and diaphragmatic function are reduced in patients with systemic lupus erythematosus compared to those with primary Sjögren's syndrome.
    Satış H; Cindil E; Salman RB; Yapar D; Temel E; Demir NB; Babaoğlu H; Gündoğdu O; Ataş N; Şendur H; Avanoğlu Güler A; Karadeniz H; Tufan A; Öztürk MA; Haznedaroğlu Ş; Göker B
    Lupus; 2020 Jun; 29(7):715-720. PubMed ID: 32338144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndrome.
    Kim SS; Richman DP; Johnson WO; Hald JK; Agius MA
    Mult Scler; 2014 Jan; 20(1):57-63. PubMed ID: 23736535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjögren's syndrome.
    Turkcapar N; Olmez U; Ozer D; Duzgun N; Duman M
    Rheumatol Int; 2006 Jul; 26(9):841-5. PubMed ID: 16328417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis.
    Motta F; Codullo V; Ramoni V; Cesari S; Ferrario G; Fiandrino G; Beneventi F; Rampello S; Johnsson H; Montecucco C; Graham GJ
    Rheumatology (Oxford); 2021 Jul; 60(7):3307-3316. PubMed ID: 33313931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis.
    Kahlmann D; Davalos-Misslitz AC; Ohl L; Stanke F; Witte T; Förster R
    BMC Genet; 2007 Jun; 8():33. PubMed ID: 17587445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
    Szabó K; Papp G; Szántó A; Tarr T; Zeher M
    Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry.
    Yan B; Huang J; Dong F; Yang L; Huang C; Gao M; Shi A; Zha W; Shi L; Hu X
    Biomed Chromatogr; 2016 Nov; 30(11):1877-1881. PubMed ID: 27061577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional profiling upon T cell stimulation reveals down-regulation of inflammatory pathways in T and B cells in SLE versus Sjögren's syndrome.
    Kwon G; Wiedemann A; Steinheuer LM; Stefanski AL; Szelinski F; Racek T; Frei AP; Hatje K; Kam-Thong T; Schubert D; Schindler T; Dörner T; Thurley K
    NPJ Syst Biol Appl; 2023 Dec; 9(1):62. PubMed ID: 38102122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis in rheumatic diseases.
    Grodzicky T; Elkon KB
    Am J Med; 2000 Jan; 108(1):73-82. PubMed ID: 11059443
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia?
    Iannuccelli C; Spinelli FR; Guzzo MP; Priori R; Conti F; Ceccarelli F; Pietropaolo M; Olivieri M; Minniti A; Alessandri C; Gattamelata A; Valesini G; Di Franco M
    Clin Exp Rheumatol; 2012; 30(6 Suppl 74):117-21. PubMed ID: 23261010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.
    Liu M; Wu X; Liu X; He J; Su Y; Guo J; Li Z
    Hum Immunol; 2015 Nov; 76(11):808-11. PubMed ID: 26429306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nailfold capillary abnormalities in patients with Sjögren's syndrome and systemic lupus erythematosus.
    Ohtsuka T
    Br J Dermatol; 1997 Jan; 136(1):94-6. PubMed ID: 9039302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
    Yang Y; Li Z; Wang L; Zhang F
    Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.